+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pruritus Therapeutics Market - Global Forecast 2026-2032- Product Image
Pruritus Therapeutics Market - Global Forecast 2026-2032- Product Image
Sale

Pruritus Therapeutics Market - Global Forecast 2026-2032

  • Report

  • 187 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 5888867
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Pruritus Therapeutics Market is projected to reach USD 7.28 Billion in 2026. It is expected to continue growing at a CAGR of 4.89%, reaching USD 9.71 Billion by 2032.

Pruritus therapeutics addresses the relief and management of itching associated with dermatologic, systemic, neurologic, and inflammatory conditions. Clinical needs vary by cause, duration, severity, affected population, and comorbidities, making accurate diagnosis and differentiated treatment selection central to patient care. The field includes topical, systemic, biologic, and supportive approaches, with treatment decisions shaped by safety, tolerability, access, and evidence across underlying diseases.

Diagnosis and Multimodal Care Are Reshaping Treatment

The landscape is shifting from symptom suppression alone toward cause-directed, multimodal management. Greater attention to inflammatory pathways, neural signaling, skin-barrier dysfunction, renal and hepatic disease, hematologic disorders, and medication-related itch is encouraging more precise assessment and therapeutic sequencing. Patient-reported severity, sleep disruption, recurrence, and quality-of-life effects are also becoming more important in evaluating treatment benefit. Persistent challenges include delayed diagnosis, treatment resistance, adverse-effect management, and uneven access to specialist care.

Artificial Intelligence Supports Precision in Itch Management

Artificial intelligence can strengthen pruritus care by helping clinicians classify likely causes, identify comorbid patterns, and prioritize patients requiring specialist assessment. Machine-learning tools may also support image interpretation, symptom tracking, clinical-trial recruitment, pharmacovigilance, and discovery of biologically relevant targets. Effective adoption depends on representative datasets, transparent validation, privacy safeguards, and workflows that preserve clinician oversight. Because itch is subjective and clinically heterogeneous, AI outputs should complement-not replace-history-taking, examination, diagnostic testing, and shared decision-making.

Regional Dynamics Differ Across Care Systems and Disease Burden

North America is characterized by broad specialist capacity, established dermatology and immunology services, and growing interest in targeted therapies, while affordability and insurance coverage remain important access considerations. Europe combines sophisticated clinical research with country-level variation in reimbursement, referral pathways, and treatment availability. Asia-Pacific includes highly diverse healthcare systems, from advanced specialty networks to settings where diagnosis and access remain limited; aging populations and chronic systemic disease are relevant considerations. Latin America faces disparities in specialist access, medicine availability, and continuity of care. The Middle East is seeing investment in modern healthcare infrastructure, alongside variation in referral systems and coverage. Africa has substantial unmet needs linked to limited specialist capacity, diagnostic constraints, infectious and systemic comorbidities, and medicine access.

Economic and Political Groups Reveal Uneven Readiness

ASEAN markets reflect diverse regulatory systems, healthcare budgets, and specialist availability, creating a need for adaptable evidence and distribution models. BRICS countries span large and varied patient populations, with local manufacturing, affordability, and public-sector access influencing treatment adoption. The European Union benefits from coordinated scientific and regulatory frameworks, but national reimbursement and implementation decisions still differ. G7 systems generally have strong research infrastructure and specialist care, while cost containment and equitable access remain priorities. GCC countries are expanding advanced healthcare capacity, though care pathways and procurement practices vary. NATO members represent heterogeneous health systems, with shared emphasis on resilience, evidence quality, and access to essential therapies.

Country-Level Priorities Reflect Distinct Clinical Contexts

Australia emphasizes specialist-led care across a geographically dispersed population. Brazil and Mexico must address regional disparities in diagnosis, reimbursement, and medicine access. Canada combines strong clinical infrastructure with challenges related to geography and provincial variation. China is advancing specialty capacity while navigating large regional differences in access and treatment pathways. France, Germany, Italy, Spain, and the United Kingdom have established healthcare systems, but differ in assessment, reimbursement, referral, and prescribing processes. India faces a large burden of untreated or undertreated chronic conditions alongside uneven specialist availability. Japan and South Korea combine advanced healthcare capabilities with aging-population needs and strong interest in clinically validated innovation. Russia’s care environment is shaped by regional access differences, healthcare resource constraints, and the availability of specialized treatment.

Priorities for Leaders in Pruritus Therapeutics

Industry leaders should prioritize therapies with clear differentiation by cause, severity, speed of relief, durability, safety, and patient-reported outcomes. Evidence plans should include diverse populations, relevant comorbidities, long-term tolerability, sleep and quality-of-life measures, and comparisons with practical standards of care. Partnerships with clinicians and patient communities can improve diagnosis pathways, adherence support, and education about treatment expectations. Access strategies should account for country-level reimbursement, public-sector procurement, distribution reliability, and affordability. Digital tools and AI should be deployed selectively, with strong validation, data governance, and human review. Organizations should also monitor emerging mechanisms, post-treatment outcomes, and unmet needs across dermatologic and systemic causes.

Methodology for a Clinically Grounded Executive Summary

This summary applies a structured qualitative synthesis of the pruritus therapeutics landscape, organized around disease biology, treatment modalities, care pathways, technology, geography, and healthcare-system readiness. Regional, group, and country perspectives are framed from the specified coverage requirements and interpreted through established clinical and access considerations. The analysis deliberately excludes market estimates, market sizing, market shares, forecasts, and company-specific assessments. Conclusions should be refreshed against current clinical guidelines, regulatory decisions, reimbursement policies, peer-reviewed evidence, and locally validated epidemiologic and outcomes data before strategic or clinical use.

The Field Is Moving Toward Cause-Directed, Accessible Care

Pruritus therapeutics is evolving toward more precise identification of underlying causes, targeted modulation of relevant pathways, and integrated measurement of symptom and quality-of-life outcomes. Progress will depend on translating biological insight into safe, durable, and accessible treatment options while improving referral, diagnosis, and continuity of care. Leaders that combine rigorous evidence, responsible technology, patient-centered design, and regionally appropriate access planning will be best positioned to address the continuing burden of chronic and difficult-to-treat itch.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Pruritus Therapeutics Market, by Therapy
7.1. Introduction
7.2. Antihistamines
7.3. Biologics
7.4. Calcineurin inhibitors
7.5. Corticosteroids
7.6. Immunosuppressant
8. Pruritus Therapeutics Market, by Route of Administration
8.1. Introduction
8.2. Injectable
8.3. Oral
8.4. Topical
9. Pruritus Therapeutics Market, by Disease Indication
9.1. Introduction
9.2. Allergic Contact Dermatitis
9.3. Atopic Dermatitis
9.4. Cutaneous T-cell
9.5. Urticaria
10. Pruritus Therapeutics Market, by Patient Demographics
10.1. Introduction
10.2. Adult Patients
10.3. Geriatric Patients
10.4. Pediatric Patients
11. Pruritus Therapeutics Market, by Distribution Channel
11.1. Introduction
11.2. Online
11.3. Offline
12. Pruritus Therapeutics Market, by End-User
12.1. Introduction
12.2. Clinics
12.3. Dermatology Centers
12.4. Homecare Settings
12.5. Hospitals
13. Pruritus Therapeutics Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. Europe
13.4. North America
13.5. Latin America
13.6. Africa
13.7. Middle East
14. Pruritus Therapeutics Market, by Group
14.1. Introduction
14.2. NATO
14.3. G7
14.4. BRICS
14.5. European Union
14.6. ASEAN
14.7. GCC
15. Pruritus Therapeutics Market, by Country
15.1. Introduction
15.2. China
15.3. United States
15.4. Japan
15.5. India
15.6. Germany
15.7. United Kingdom
15.8. Australia
15.9. France
15.10. South Korea
15.11. Italy
15.12. Canada
15.13. Russia
15.14. Brazil
15.15. Mexico
15.16. Spain
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. AbbVie Inc.
17.2. Asana BioSciences, LLC
17.3. Astellas Pharma Inc.
17.4. Avior Bio, Inc.
17.5. Bausch Health Companies Inc.
17.6. Bayer AG
17.7. Cara Therapeutics, Inc.
17.8. Eli Lilly and Company
17.9. EPI Health, LLC
17.10. Escient Pharmaceuticals, Inc.
17.11. Evelo Biosciences, Inc.
17.12. Galderma S.A.
17.13. GSK plc
17.14. LEO Pharma A/S
17.15. Mallinckrodt plc
17.16. MC2 Therapeutics A/S
17.17. Mirum Pharmaceuticals, Inc.
17.18. NeRRe Therapeutics Ltd.
17.19. Novartis AG
17.20. Pfizer Inc.
17.21. Regeneron Pharmaceuticals, Inc.
17.22. Sanofi
17.23. Teva Pharmaceutical Industries Ltd.
17.24. Toray Industries, Inc.
17.25. Trevi Therapeutics, Inc.
17.26. Vanda Pharmaceuticals Inc.
17.27. Viatris Inc.
18. Key Experts
List of Figures
FIGURE 1. Global Pruritus Therapeutics Market, Years Considered for the Study
FIGURE 2. Global Pruritus Therapeutics Market, Research Design
FIGURE 3. Global Pruritus Therapeutics Market, Research Framework
FIGURE 4. Global Pruritus Therapeutics Market, Data Triangulation
FIGURE 5. Global Pruritus Therapeutics Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Pruritus Therapeutics Market Size, by Therapy, 2025 vs 2032 (%)
FIGURE 7. Global Pruritus Therapeutics Market Size, by Therapy, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Pruritus Therapeutics Market Size, by Route of Administration, 2025 vs 2032 (%)
FIGURE 9. Global Pruritus Therapeutics Market Size, by Route of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Pruritus Therapeutics Market Size, by Disease Indication, 2025 vs 2032 (%)
FIGURE 11. Global Pruritus Therapeutics Market Size, by Disease Indication, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Pruritus Therapeutics Market Size, by Patient Demographics, 2025 vs 2032 (%)
FIGURE 13. Global Pruritus Therapeutics Market Size, by Patient Demographics, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Pruritus Therapeutics Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 15. Global Pruritus Therapeutics Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Pruritus Therapeutics Market Size, by End-User, 2025 vs 2032 (%)
FIGURE 17. Global Pruritus Therapeutics Market Size, by End-User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Pruritus Therapeutics Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Pruritus Therapeutics Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Pruritus Therapeutics Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Pruritus Therapeutics Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Pruritus Therapeutics Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Pruritus Therapeutics Market Share, by Key Player, 2025
List of Tables
TABLE 1. Global Pruritus Therapeutics Market Segmentation & Coverage
TABLE 2. Global Pruritus Therapeutics Market Size, 2017-2032 (USD Million)
TABLE 3. Global Pruritus Therapeutics Market Size, by Therapy, 2017-2032 (USD Million)
TABLE 4. Global Antihistamines Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Antihistamines Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Antihistamines Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Biologics Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Biologics Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Biologics Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Calcineurin inhibitors Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Calcineurin inhibitors Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Calcineurin inhibitors Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Corticosteroids Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Corticosteroids Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Corticosteroids Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Immunosuppressant Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Immunosuppressant Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Immunosuppressant Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Pruritus Therapeutics Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 20. Global Injectable Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Injectable Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Injectable Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Topical Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Topical Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Topical Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Pruritus Therapeutics Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 30. Global Allergic Contact Dermatitis Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Allergic Contact Dermatitis Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Allergic Contact Dermatitis Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Atopic Dermatitis Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Atopic Dermatitis Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Atopic Dermatitis Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Cutaneous T-cell Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Cutaneous T-cell Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Cutaneous T-cell Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Urticaria Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Urticaria Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Urticaria Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Pruritus Therapeutics Market Size, by Patient Demographics, 2017-2032 (USD Million)
TABLE 43. Global Adult Patients Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Adult Patients Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Adult Patients Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Geriatric Patients Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Geriatric Patients Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Geriatric Patients Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Pediatric Patients Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Pediatric Patients Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Pediatric Patients Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Pruritus Therapeutics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 53. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global Pruritus Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 60. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Dermatology Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Dermatology Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Dermatology Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Homecare Settings Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Homecare Settings Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Homecare Settings Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Pruritus Therapeutics Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Pruritus Therapeutics Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Pruritus Therapeutics Market Size, by Therapy, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Pruritus Therapeutics Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Pruritus Therapeutics Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific Pruritus Therapeutics Market Size, by Patient Demographics, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific Pruritus Therapeutics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific Pruritus Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 80. Europe Pruritus Therapeutics Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Europe Pruritus Therapeutics Market Size, by Therapy, 2017-2032 (USD Million)
TABLE 82. Europe Pruritus Therapeutics Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 83. Europe Pruritus Therapeutics Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 84. Europe Pruritus Therapeutics Market Size, by Patient Demographics, 2017-2032 (USD Million)
TABLE 85. Europe Pruritus Therapeutics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 86. Europe Pruritus Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 87. North America Pruritus Therapeutics Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. North America Pruritus Therapeutics Market Size, by Therapy, 2017-2032 (USD Million)
TABLE 89. North America Pruritus Therapeutics Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 90. North America Pruritus Therapeutics Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 91. North America Pruritus Therapeutics Market Size, by Patient Demographics, 2017-2032 (USD Million)
TABLE 92. North America Pruritus Therapeutics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 93. North America Pruritus Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 94. Latin America Pruritus Therapeutics Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Latin America Pruritus Therapeutics Market Size, by Therapy, 2017-2032 (USD Million)
TABLE 96. Latin America Pruritus Therapeutics Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 97. Latin America Pruritus Therapeutics Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 98. Latin America Pruritus Therapeutics Market Size, by Patient Demographics, 2017-2032 (USD Million)
TABLE 99. Latin America Pruritus Therapeutics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 100. Latin America Pruritus Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 101. Africa Pruritus Therapeutics Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Africa Pruritus Therapeutics Market Size, by Therapy, 2017-2032 (USD Million)
TABLE 103. Africa Pruritus Therapeutics Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 104. Africa Pruritus Therapeutics Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 105. Africa Pruritus Therapeutics Market Size, by Patient Demographics, 2017-2032 (USD Million)
TABLE 106. Africa Pruritus Therapeutics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 107. Africa Pruritus Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 108. Middle East Pruritus Therapeutics Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Middle East Pruritus Therapeutics Market Size, by Therapy, 2017-2032 (USD Million)
TABLE 110. Middle East Pruritus Therapeutics Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 111. Middle East Pruritus Therapeutics Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 112. Middle East Pruritus Therapeutics Market Size, by Patient Demographics, 2017-2032 (USD Million)
TABLE 113. Middle East Pruritus Therapeutics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 114. Middle East Pruritus Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 115. Global Pruritus Therapeutics Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. NATO Pruritus Therapeutics Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. NATO Pruritus Therapeutics Market Size, by Therapy, 2017-2032 (USD Million)
TABLE 118. NATO Pruritus Therapeutics Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 119. NATO Pruritus Therapeutics Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 120. NATO Pruritus Therapeutics Market Size, by Patient Demographics, 2017-2032 (USD Million)
TABLE 121. NATO Pruritus Therapeutics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 122. NATO Pruritus Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 123. G7 Pruritus Therapeutics Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. G7 Pruritus Therapeutics Market Size, by Therapy, 2017-2032 (USD Million)
TABLE 125. G7 Pruritus Therapeutics Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 126. G7 Pruritus Therapeutics Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 127. G7 Pruritus Therapeutics Market Size, by Patient Demographics, 2017-2032 (USD Million)
TABLE 128. G7 Pruritus Therapeutics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 129. G7 Pruritus Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 130. BRICS Pruritus Therapeutics Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. BRICS Pruritus Therapeutics Market Size, by Therapy, 2017-2032 (USD Million)
TABLE 132. BRICS Pruritus Therapeutics Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 133. BRICS Pruritus Therapeutics Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 134. BRICS Pruritus Therapeutics Market Size, by Patient Demographics, 2017-2032 (USD Million)
TABLE 135. BRICS Pruritus Therapeutics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 136. BRICS Pruritus Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 137. European Union Pruritus Therapeutics Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. European Union Pruritus Therapeutics Market Size, by Therapy, 2017-2032 (USD Million)
TABLE 139. European Union Pruritus Therapeutics Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 140. European Union Pruritus Therapeutics Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 141. European Union Pruritus Therapeutics Market Size, by Patient Demographics, 2017-2032 (USD Million)
TABLE 142. European Union Pruritus Therapeutics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 143. European Union Pruritus Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 144. ASEAN Pruritus Therapeutics Market Size, by Group, 2017-2032 (USD Million)
TABLE 145. ASEAN Pruritus Therapeutics Market Size, by Therapy, 2017-2032 (USD Million)
TABLE 146. ASEAN Pruritus Therapeutics Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 147. ASEAN Pruritus Therapeutics Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 148. ASEAN Pruritus Therapeutics Market Size, by Patient Demographics, 2017-2032 (USD Million)
TABLE 149. ASEAN Pruritus Therapeutics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 150. ASEAN Pruritus Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 151. GCC Pruritus Therapeutics Market Size, by Group, 2017-2032 (USD Million)
TABLE 152. GCC Pruritus Therapeutics Market Size, by Therapy, 2017-2032 (USD Million)
TABLE 153. GCC Pruritus Therapeutics Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 154. GCC Pruritus Therapeutics Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 155. GCC Pruritus Therapeutics Market Size, by Patient Demographics, 2017-2032 (USD Million)
TABLE 156. GCC Pruritus Therapeutics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 157. GCC Pruritus Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 158. Global Pruritus Therapeutics Market Size, by Country, 2017-2032 (USD Million)
TABLE 159. China Pruritus Therapeutics Market Size, 2017-2032 (USD Million)
TABLE 160. China Pruritus Therapeutics Market Size, by Therapy, 2017-2032 (USD Million)
TABLE 161. China Pruritus Therapeutics Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 162. China Pruritus Therapeutics Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 163. China Pruritus Therapeutics Market Size, by Patient Demographics, 2017-2032 (USD Million)
TABLE 164. China Pruritus Therapeutics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 165. China Pruritus Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 166. United States Pruritus Therapeutics Market Size, 2017-2032 (USD Million)
TABLE 167. United States Pruritus Therapeutics Market Size, by Therapy, 2017-2032 (USD Million)
TABLE 168. United States Pruritus Therapeutics Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 169. United States Pruritus Therapeutics Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 170. United States Pruritus Therapeutics Market Size, by Patient Demographics, 2017-2032 (USD Million)
TABLE 171. United States Pruritus Therapeutics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 172. United States Pruritus Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 173. Japan Pruritus Therapeutics Market Size, 2017-2032 (USD Million)
TABLE 174. Japan Pruritus Therapeutics Market Size, by Therapy, 2017-2032 (USD Million)
TABLE 175. Japan Pruritus Therapeutics Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 176. Japan Pruritus Therapeutics Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 177. Japan Pruritus Therapeutics Market Size, by Patient Demographics, 2017-2032 (USD Million)
TABLE 178. Japan Pruritus Therapeutics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 179. Japan Pruritus Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 180. India Pruritus Therapeutics Market Size, 2017-2032 (USD Million)
TABLE 181. India Pruritus Therapeutics Market Size, by Therapy, 2017-2032 (USD Million)
TABLE 182. India Pruritus Therapeutics Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 183. India Pruritus Therapeutics Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 184. India Pruritus Therapeutics Market Size, by Patient Demographics, 2017-2032 (USD Million)
TABLE 185. India Pruritus Therapeutics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 186. India Pruritus Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 187. Germany Pruritus Therapeutics Market Size, 2017-2032 (USD Million)
TABLE 188. Germany Pruritus Therapeutics Market Size, by Therapy, 2017-2032 (USD Million)
TABLE 189. Germany Pruritus Therapeutics Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 190. Germany Pruritus Therapeutics Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 191. Germany Pruritus Therapeutics Market Size, by Patient Demographics, 2017-2032 (USD Million)
TABLE 192. Germany Pruritus Therapeutics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 193. Germany Pruritus Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 194. United Kingdom Pruritus Therapeutics Market Size, 2017-2032 (USD Million)
TABLE 195. United Kingdom Pruritus Therapeutics Market Size, by Therapy, 2017-2032 (USD Million)
TABLE 196. United Kingdom Pruritus Therapeutics Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 197. United Kingdom Pruritus Therapeutics Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 198. United Kingdom Pruritus Therapeutics Market Size, by Patient Demographics, 2017-2032 (USD Million)
TABLE 199. United Kingdom Pruritus Therapeutics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 200. United Kingdom Pruritus Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 201. Australia Pruritus Therapeutics Market Size, 2017-2032 (USD Million)
TABLE 202. Australia Pruritus Therapeutics Market Size, by Therapy, 2017-2032 (USD Million)
TABLE 203. Australia Pruritus Therapeutics Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 204. Australia Pruritus Therapeutics Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 205. Australia Pruritus Therapeutics Market Size, by Patient Demographics, 2017-2032 (USD Million)
TABLE 206. Australia Pruritus Therapeutics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 207. Australia Pruritus Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 208. France Pruritus Therapeutics Market Size, 2017-2032 (USD Million)
TABLE 209. France Pruritus Therapeutics Market Size, by Therapy, 2017-2032 (USD Million)
TABLE 210. France Pruritus Therapeutics Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 211. France Pruritus Therapeutics Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 212. France Pruritus Therapeutics Market Size, by Patient Demographics, 2017-2032 (USD Million)
TABLE 213. France Pruritus Therapeutics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 214. France Pruritus Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 215. South Korea Pruritus Therapeutics Market Size, 2017-2032 (USD Million)
TABLE 216. South Korea Pruritus Therapeutics Market Size, by Therapy, 2017-2032 (USD Million)
TABLE 217. South Korea Pruritus Therapeutics Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 218. South Korea Pruritus Therapeutics Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 219. South Korea Pruritus Therapeutics Market Size, by Patient Demographics, 2017-2032 (USD Million)
TABLE 220. South Korea Pruritus Therapeutics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 221. South Korea Pruritus Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 222. Italy Pruritus Therapeutics Market Size, 2017-2032 (USD Million)
TABLE 223. Italy Pruritus Therapeutics Market Size, by Therapy, 2017-2032 (USD Million)
TABLE 224. Italy Pruritus Therapeutics Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 225. Italy Pruritus Therapeutics Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 226. Italy Pruritus Therapeutics Market Size, by Patient Demographics, 2017-2032 (USD Million)
TABLE 227. Italy Pruritus Therapeutics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 228. Italy Pruritus Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 229. Canada Pruritus Therapeutics Market Size, 2017-2032 (USD Million)
TABLE 230. Canada Pruritus Therapeutics Market Size, by Therapy, 2017-2032 (USD Million)
TABLE 231. Canada Pruritus Therapeutics Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 232. Canada Pruritus Therapeutics Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 233. Canada Pruritus Therapeutics Market Size, by Patient Demographics, 2017-2032 (USD Million)
TABLE 234. Canada Pruritus Therapeutics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 235. Canada Pruritus Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 236. Russia Pruritus Therapeutics Market Size, 2017-2032 (USD Million)
TABLE 237. Russia Pruritus Therapeutics Market Size, by Therapy, 2017-2032 (USD Million)
TABLE 238. Russia Pruritus Therapeutics Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 239. Russia Pruritus Therapeutics Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 240. Russia Pruritus Therapeutics Market Size, by Patient Demographics, 2017-2032 (USD Million)
TABLE 241. Russia Pruritus Therapeutics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 242. Russia Pruritus Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 243. Brazil Pruritus Therapeutics Market Size, 2017-2032 (USD Million)
TABLE 244. Brazil Pruritus Therapeutics Market Size, by Therapy, 2017-2032 (USD Million)
TABLE 245. Brazil Pruritus Therapeutics Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 246. Brazil Pruritus Therapeutics Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 247. Brazil Pruritus Therapeutics Market Size, by Patient Demographics, 2017-2032 (USD Million)
TABLE 248. Brazil Pruritus Therapeutics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 249. Brazil Pruritus Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 250. Mexico Pruritus Therapeutics Market Size, 2017-2032 (USD Million)
TABLE 251. Mexico Pruritus Therapeutics Market Size, by Therapy, 2017-2032 (USD Million)
TABLE 252. Mexico Pruritus Therapeutics Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 253. Mexico Pruritus Therapeutics Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 254. Mexico Pruritus Therapeutics Market Size, by Patient Demographics, 2017-2032 (USD Million)
TABLE 255. Mexico Pruritus Therapeutics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 256. Mexico Pruritus Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 257. Spain Pruritus Therapeutics Market Size, 2017-2032 (USD Million)
TABLE 258. Spain Pruritus Therapeutics Market Size, by Therapy, 2017-2032 (USD Million)
TABLE 259. Spain Pruritus Therapeutics Market Size, by Route of Administration, 2017-2032 (USD Million)
TABLE 260. Spain Pruritus Therapeutics Market Size, by Disease Indication, 2017-2032 (USD Million)
TABLE 261. Spain Pruritus Therapeutics Market Size, by Patient Demographics, 2017-2032 (USD Million)
TABLE 262. Spain Pruritus Therapeutics Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 263. Spain Pruritus Therapeutics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 264. Global Pruritus Therapeutics Market Share, by Key Player, 2025
TABLE 265. Global Pruritus Therapeutics Market, Key Experts

Companies Mentioned

  • AbbVie Inc.
  • Asana BioSciences, LLC
  • Astellas Pharma Inc.
  • Avior Bio, Inc.
  • Bausch Health Companies Inc.
  • Bayer AG
  • Cara Therapeutics, Inc.
  • Eli Lilly and Company
  • EPI Health, LLC
  • Escient Pharmaceuticals, Inc.
  • Evelo Biosciences, Inc.
  • Galderma S.A.
  • GSK plc
  • LEO Pharma A/S
  • Mallinckrodt plc
  • MC2 Therapeutics A/S
  • Mirum Pharmaceuticals, Inc.
  • NeRRe Therapeutics Ltd.
  • Novartis AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Sanofi
  • Teva Pharmaceutical Industries Ltd.
  • Toray Industries, Inc.
  • Trevi Therapeutics, Inc.
  • Vanda Pharmaceuticals Inc.
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages187
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 7.28 Billion
Forecasted Market Value ( USD ) by 2032 $ 9.71 Billion
Compound Annual Growth Rate4.8%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Pruritus Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Pruritus Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 115 Pages
  • Global
From
Chronic Pruritus Therapeutics Market Report 2026 - Product Image

Chronic Pruritus Therapeutics Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Pruritus Therapeutic Market Report 2026 - Product Image

Pruritus Therapeutic Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Pruritus Therapeutics - Global Strategic Business Report - Product Image

Pruritus Therapeutics - Global Strategic Business Report

  • Report
  • 192 Pages
  • Global
From
Pruritus Therapeutics Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type, Disease Type - Product Image

Pruritus Therapeutics Market Outlook 2026-2034: Market Share, and Growth Analysis by Product Type, Disease Type

  • Report
  • 160 Pages
  • Global
From

About the Pruritus Drug Market

Pruritus, or itching, is a common symptom of many skin conditions and can be treated with dermatological drugs. These drugs are typically divided into two categories: topical and systemic. Topical drugs are applied directly to the skin and can include corticosteroids, calcineurin inhibitors, and antihistamines. Systemic drugs are taken orally or injected and can include anticonvulsants, antidepressants, and opioids. The pruritus drug market is a subset of the larger dermatological drug market. It is composed of a variety of drugs used to treat itching, including both topical and systemic treatments. These drugs are used to treat a wide range of skin conditions, from eczema and psoriasis to allergic reactions and insect bites. Some companies in the pruritus drug market include Pfizer, Novartis, GlaxoSmithKline, Sanofi, and Merck. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.